Live Breaking News & Updates on Wellington Shields|Page 3

Stay updated with breaking news from Wellington shields. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

StockNews.com Begins Coverage on CASI Pharmaceuticals (NASDAQ:CASI)

StockNews.com assumed coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research note issued to investors on Monday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reiterated a buy rating and issued a $10.00 target price on shares of CASI Pharmaceuticals in a research report […] ....

United States , New Zealand General , New Zealand , Pharmaceuticals Inc , Pharmaceuticals Stock Performance , Citigroup Inc , Pharmaceuticals Company Profile , Susquehanna International Group , Renaissance Technologies , Wellington Shields Co , Virtu Financial , Pharmaceuticals Daily , Free Report , International Group , Wellington Shields , Get Free Report , Casi Pharmaceuticals , Nasdaq Casi , Initiated Coverage , Stocknews Com ,

StockNews.com Initiates Coverage on CASI Pharmaceuticals (NASDAQ:CASI)

StockNews.com assumed coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research note released on Sunday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reiterated a buy rating and issued a $10.00 price target on shares of CASI Pharmaceuticals in a research note on Monday, […] ....

New Zealand General , New Zealand , United States , Pharmaceuticals Daily , Citigroup Inc , Renaissance Technologies , Virtu Financial , Pharmaceuticals Company Profile , Pharmaceuticals Inc , Pharmaceuticals Stock Performance , Wellington Shields Co , Susquehanna International Group , Free Report , Get Free Report , International Group , Wellington Shields , Casi Pharmaceuticals , Nasdaq Casi , Initiated Coverage , Stocknews Com ,

CASI Pharmaceuticals (NASDAQ:CASI) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research report sent to investors on Sunday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reaffirmed a buy rating and issued a $10.00 target price on shares of CASI Pharmaceuticals in a research report […] ....

United States , New Zealand General , New Zealand , Citigroup Inc , Pharmaceuticals Daily , Susquehanna International Group , Virtu Financial , Pharmaceuticals Trading Down , Renaissance Technologies , Pharmaceuticals Inc , Wellington Shields Co , Free Report , Trading Down , Get Free Report , International Group , Wellington Shields , Casi Pharmaceuticals , Nasdaq Casi , Initiated Coverage , Stocknews Com ,